Tirzepatide

Tirzepatide

Tirzepatide is a synthetic dual receptor agonist peptide designed to activate both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual-incretin mechanism has made it a widely studied compound in metabolic and endocrine research, providing investigators with a valuable tool for exploring the interactions between these two signaling pathways.

In laboratory and preclinical research, tirzepatide has been investigated for its potential effects on:

• Dual GIP and GLP-1 receptor signaling
• Metabolic regulation
• Glucose homeostasis
• Insulin signaling pathways
• Appetite signaling
• Energy metabolism
• Lipid metabolism
• Fatty acid oxidation
• Adipose tissue biology
• Mitochondrial function
• Cellular energy balance
• Nutrient sensing pathways
• Incretin hormone physiology
• Receptor pharmacology
• Endocrine signaling mechanisms
• Cellular metabolic adaptation

Tirzepatide continues to serve as an important research compound for studying incretin biology, receptor activation, and the complex molecular pathways involved in metabolic regulation. Ongoing investigations aim to further characterize its pharmacological profile, receptor interactions, and downstream cellular signaling mechanisms.

Research Use Only (RUO): This product is intended exclusively for laboratory and scientific research. It is not intended for human or veterinary use, diagnosis, treatment, or consumption.